CalciMedica (CALC) Competitors $1.56 +0.02 (+1.30%) As of 04/17/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CALC vs. FTLF, XBIT, CHRS, SLS, CCCC, BHST, OPTN, TIL, COYA, and ORMPShould you be buying CalciMedica stock or one of its competitors? The main competitors of CalciMedica include FitLife Brands (FTLF), XBiotech (XBIT), Coherus BioSciences (CHRS), SELLAS Life Sciences Group (SLS), C4 Therapeutics (CCCC), BioHarvest Sciences (BHST), OptiNose (OPTN), Instil Bio (TIL), Coya Therapeutics (COYA), and Oramed Pharmaceuticals (ORMP). These companies are all part of the "pharmaceutical products" industry. CalciMedica vs. FitLife Brands XBiotech Coherus BioSciences SELLAS Life Sciences Group C4 Therapeutics BioHarvest Sciences OptiNose Instil Bio Coya Therapeutics Oramed Pharmaceuticals CalciMedica (NASDAQ:CALC) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, community ranking, analyst recommendations, earnings and media sentiment. Is CALC or FTLF more profitable? FitLife Brands has a net margin of 13.38% compared to CalciMedica's net margin of 0.00%. FitLife Brands' return on equity of 28.03% beat CalciMedica's return on equity.Company Net Margins Return on Equity Return on Assets CalciMedicaN/A -164.24% -103.53% FitLife Brands 13.38%28.03%15.13% Does the MarketBeat Community favor CALC or FTLF? CalciMedica received 14 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 94.44% of users gave CalciMedica an outperform vote while only 60.00% of users gave FitLife Brands an outperform vote. CompanyUnderperformOutperformCalciMedicaOutperform Votes1794.44% Underperform Votes15.56%FitLife BrandsOutperform Votes360.00% Underperform Votes240.00% Which has more risk & volatility, CALC or FTLF? CalciMedica has a beta of 1.22, meaning that its share price is 22% more volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Do analysts prefer CALC or FTLF? CalciMedica currently has a consensus target price of $18.00, indicating a potential upside of 1,061.29%. FitLife Brands has a consensus target price of $20.50, indicating a potential upside of 53.67%. Given CalciMedica's higher possible upside, research analysts plainly believe CalciMedica is more favorable than FitLife Brands.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CalciMedica 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00FitLife Brands 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has better earnings and valuation, CALC or FTLF? FitLife Brands has higher revenue and earnings than CalciMedica. CalciMedica is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCalciMedicaN/AN/A-$34.36M-$1.19-1.30FitLife Brands$64.47M1.91$5.30M$0.8415.88 Do institutionals & insiders have more ownership in CALC or FTLF? 2.3% of FitLife Brands shares are held by institutional investors. 41.5% of CalciMedica shares are held by company insiders. Comparatively, 61.3% of FitLife Brands shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media favor CALC or FTLF? In the previous week, FitLife Brands had 3 more articles in the media than CalciMedica. MarketBeat recorded 4 mentions for FitLife Brands and 1 mentions for CalciMedica. FitLife Brands' average media sentiment score of 1.21 beat CalciMedica's score of 0.00 indicating that FitLife Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CalciMedica 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral FitLife Brands 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryFitLife Brands beats CalciMedica on 13 of the 17 factors compared between the two stocks. Get CalciMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for CALC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CALC vs. The Competition Export to ExcelMetricCalciMedicaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.90M$6.45B$5.30B$7.34BDividend YieldN/A3.23%5.12%4.30%P/E Ratio-1.446.8921.8017.78Price / SalesN/A231.03379.9697.74Price / CashN/A65.6738.2634.64Price / Book1.095.916.443.97Net Income-$34.36M$142.72M$3.21B$247.65M7 Day Performance0.98%4.38%2.85%1.80%1 Month Performance-26.54%-12.76%-8.64%-6.98%1 Year Performance-61.44%-9.69%11.38%1.34% CalciMedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CALCCalciMedica1.5155 of 5 stars$1.55+0.6%$18.00+1,061.3%-62.9%$20.90MN/A-1.4430News CoverageFTLFFitLife Brands4.2379 of 5 stars$10.47+0.7%$20.50+95.8%-9.9%$96.52M$64.47M12.3920Positive NewsGap UpHigh Trading VolumeXBITXBiotech0.8249 of 5 stars$3.15+9.8%N/A-63.7%$96.04M$4.01M-2.92100Positive NewsGap DownCHRSCoherus BioSciences3.621 of 5 stars$0.82+5.1%$5.38+554.3%-47.9%$95.21M$266.96M-10.27330Analyst DowngradeNews CoverageSLSSELLAS Life Sciences Group0.1761 of 5 stars$1.04flatN/A-7.8%$94.48M$1M-1.5110CCCCC4 Therapeutics2.4695 of 5 stars$1.33+1.5%$12.50+839.8%-81.8%$94.42M$35.58M-0.78150News CoverageBHSTBioHarvest SciencesN/A$5.60+1.1%$13.00+132.1%N/A$91.98M$25.19M-4.48N/APositive NewsOPTNOptiNose3.2933 of 5 stars$9.10flat$9.00-1.1%-40.1%$91.66M$78.23M-2.17190Short Interest ↓Positive NewsHigh Trading VolumeTILInstil Bio2.0875 of 5 stars$13.88-5.0%$114.00+721.3%+45.9%$90.58MN/A-1.20410COYACoya Therapeutics2.4253 of 5 stars$5.39-1.1%$17.00+215.4%-36.2%$90.15M$3.55M-8.296Positive NewsGap UpORMPOramed Pharmaceuticals1.4808 of 5 stars$2.10flatN/A-7.7%$85.79M$1.34M19.0910Gap Down Related Companies and Tools Related Companies FitLife Brands Alternatives XBiotech Alternatives Coherus BioSciences Alternatives SELLAS Life Sciences Group Alternatives C4 Therapeutics Alternatives BioHarvest Sciences Alternatives OptiNose Alternatives Instil Bio Alternatives Coya Therapeutics Alternatives Oramed Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CALC) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThey Won’t Tell You This About GoldInflation, digital currency, and government policy are quietly eating away at your savings — and most people w...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CALC Stock Free CALC Stock Alerts